TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Clinical trial NCT00451321 · TERMINATED

Trial details

NCT number: NCT00451321
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2006-07-31
Primary completion: 2011-12-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.